Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 46 AL 60

[The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies]

Vasenina EE, Gankina OA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):32-36. doi: 10.17116/jnevro201811806232.

Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications

Tumminia A, Vinciguerra F, Parisi M, Frittitta L.

Int J Mol Sci. 2018 Oct 24;19(11):3306. doi: 10.3390/ijms19113306.

Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease

Sivanesan S, Mundugaru R, Rajadas J.

Oxid Med Cell Longev. 2018 Oct 21;2018:2764831. doi: 10.1155/2018/2764831. eCollection 2018.

APP signaling in Alzheimer's disease

Bignante EA, Lorenzo A.

Aging (Albany NY). 2018 Nov 13;10(11):3063-3064. doi: 10.18632/aging.101641.

p66Shc activation promotes increased oxidative phosphorylation and renders CNS cells more vulnerable to amyloid beta toxicity

Lone A, Harris RA, Singh O, Betts DH, Cumming RC.

Sci Rep. 2018 Nov 20;8(1):17081. doi: 10.1038/s41598-018-35114-y.

Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology

Pchitskaya EI, Zhemkov VA, Bezprozvanny IB.

Biochemistry (Mosc). 2018 Sep;83(9):1068-1074. doi: 10.1134/S0006297918090080.

Current state of Alzheimer's fluid biomarkers

Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O'Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, Tong G, Trojanowski JQ, Zetterberg H, Blennow K.

Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.

Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD)

Wang Y, Zhang J, Lei Y, Zhao J.

Stem Cell Res. 2018 Dec;33:265-268. doi: 10.1016/j.scr.2018.11.008. Epub 2018 Nov 28.

Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease

Rad SK, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S, Prabhu G.

Drug Des Devel Ther. 2018 Nov 22;12:3999-4021. doi: 10.2147/DDDT.S173970. eCollection 2018.

Potential Role of Fluoride in the Etiopathogenesis of Alzheimer's Disease

Goschorska M, Baranowska-Bosiacka I, Gutowska I, Metryka E, Skórka-Majewicz M, Chlubek D.

Int J Mol Sci. 2018 Dec 9;19(12):3965. doi: 10.3390/ijms19123965.

Treatment of epilepsy for people with Alzheimer's disease

Liu J, Wang LN, Wu LY, Wang YP.

Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD011922. doi: 10.1002/14651858.CD011922.pub3.

Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease

Ruiz Vargas E, Sposato LA, Lee SAW, Hachinski V, Cipriano LE.

Stroke. 2018 Dec;49(12):2844-2850. doi: 10.1161/STROKEAHA.118.022596.

RAB10: an Alzheimer's disease resilience locus and potential drug target

Tavana JP, Rosene M, Jensen NO, Ridge PG, Kauwe JS, Karch CM.

Clin Interv Aging. 2018 Dec 28;14:73-79. doi: 10.2147/CIA.S159148. eCollection 2019.

Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms

Croze ML, Zimmer L.

J Alzheimers Dis. 2018;62(2):503-522. doi: 10.3233/JAD-170857.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias